Motor-cognitive exercise for Parkinson's (NCT07465107)
Improve gait balance and attention
- Trial ID
- NCT07465107
- Official Title
- Motor and Cognitive Exercise in Parkinson's Disease. A Feasibility Randomized Clinical Trial
- Goal
- Improve gait balance and attention
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Annemette Lokkegaard
- Study Type
- INTERVENTIONAL
- Enrollment
- 48 participants
- Conditions
- Parkinson Disease (PD)
- Interventions
- Motor-cognitive exercise, Usual Care
Summary For Families
The goal is to test whether a combined motor and cognitive exercise program can be delivered safely and help with common Parkinson's problems like gait, balance, attention, and multitasking. The program pairs physical movements, such as walking or balance drills, with cognitive tasks like memory or attention challenges to train the brain networks that control both mobility and thinking; it is a non-drug approach meant to complement medications like levodopa and is compared to usual care. The trial is enrolling adults 18 and older with Parkinson's by MDS criteria, with symptoms for at least four years, who can walk independently, and it excludes those with Parkinson's disease dementia.
Locations
- Department of Neurology, Bispebjerg and Frederiksberg Hospital, Copenhagen NV, Denmark
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Motor-cognitive exercise. The goal is to test whether a combined motor and cognitive exercise program can be delivered safely and help with common Parkinson's problems like gait, balance, attention, and multitasking. The program pairs physical movements, such as walking or balance drills, with cognitive tasks like memory or attention challenges to train the brain networks that control both mobility and thinking; it is a non-drug approach meant to complement medications like levodopa and is compared to usual care. The trial is enrolling adults 18 and older with Parkinson's by MDS criteria, with symptoms for at least four years, who can walk independently, and it excludes those with Parkinson's disease dementia.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 11 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- There is no placebo group. Everyone receives an active treatment; the study compares one treatment against another.
- How many visits does this trial involve?
- Participants will be examined at baseline, after 12 weeks, and again at 6 and 12 months after baseline.